Bicycle Therapeutics (BCYC) Return on Sales (2018 - 2025)
Historic Return on Sales for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to 5.04%.
- Bicycle Therapeutics' Return on Sales rose 139500.0% to 5.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 44.71%, marking a year-over-year increase of 720700.0%. This contributed to the annual value of 145.68% for FY2024, which is 1115000.0% down from last year.
- Bicycle Therapeutics' Return on Sales amounted to 5.04% in Q3 2025, which was up 139500.0% from 27.04% recorded in Q2 2025.
- Bicycle Therapeutics' Return on Sales' 5-year high stood at 3.03% during Q4 2023, with a 5-year trough of 27.04% in Q2 2025.
- Over the past 5 years, Bicycle Therapeutics' median Return on Sales value was 6.09% (recorded in 2025), while the average stood at 7.91%.
- In the last 5 years, Bicycle Therapeutics' Return on Sales soared by 194300bps in 2022 and then tumbled by -227900bps in 2025.
- Bicycle Therapeutics' Return on Sales (Quarter) stood at 23.83% in 2021, then skyrocketed by 82bps to 4.4% in 2022, then soared by 169bps to 3.03% in 2023, then plummeted by -37bps to 1.9% in 2024, then plummeted by -365bps to 5.04% in 2025.
- Its Return on Sales stands at 5.04% for Q3 2025, versus 27.04% for Q2 2025 and 6.09% for Q1 2025.